This review focuses on targeted therapies related to these pathways of interest for the treatment of advanced urothelial carcinoma, describing the evidence to support further investigation of these approaches.
Brandon P. Verdoorn, MD
Advertisement
Articles by Brandon P. Verdoorn, MD
Advertisement
Latest Updated Articles
- Targeted Therapy in Advanced Urothelial Carcinoma
March 16th 2013
Advertisement
Advertisement
Trending on CancerNetwork
1
Data Readouts to Watch at the 2026 ASCO Annual Meeting
2
Alpha DaRT Elicits 100% Local Disease Control in Pancreatic Cancer
3
Navigating The Dynamic Landscape of Stem Cell Transplantation
4
FDA OKs Updated Guardant360 Liquid CDx with Expanded Molecular Profiling
5